Biotia leverages advanced genomic technologies and artificial intelligence to enhance infectious disease diagnostics and public health surveillance. One of their key products, GeoSeeq, serves as a global pandemic early warning system that integrates local health data with climate information to predict and mitigate outbreaks before they escalate into pandemics. This platform fortifies local laboratories, particularly in underserved areas, by providing modern sequencing technology and training, thereby creating a global stream of health data that enables high-resolution mapping of disease patterns. Additionally, Biotia's BIOTIA-DX tool offers a clinically validated metagenomics approach that surpasses traditional culture methods in sensitivity and accuracy, allowing for the identification of pathogens in various clinical specimens.

For clinicians, Biotia has developed the BIOTIA-ID assay, which is a genomics-based diagnostic tool designed for immunocompromised patients and those with complex infections. This assay is pending regulatory approval and aims to improve the accuracy of infectious disease detection, particularly in urinary tract infections, where conventional methods often fail. The BIOTIA-ID Urine test has been clinically validated to provide high sensitivity and specificity for a range of pathogens, addressing the limitations of existing diagnostic technologies. Overall, Biotia's innovative use of genomics and AI positions it at the forefront of transforming infectious disease diagnostics and enhancing global health responses.

United States

Biotia is a health tech company launched from Jacobs Technion-Cornell Institute at Cornell Tech in association with Weill Cornell Medicine, located in New York, NY, that leverages DNA sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. Biotia is developing a next-generation sequencing-based test for COVID-19 that characterizes genetic variance across the whole viral genome.

Biotia

Company Details